Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Explore Cerebrospinal Fluid and Blood Biomarkers in Participants With Angelman Syndrome

NCT04103333 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT04103333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04103333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Explore Cerebrospinal Fluid and Blood Biomarkers in Participants With Angelman Syndrome
Lead sponsor
Biogen
Phase
Phase 1
Overall status
Completed
Start date
December 18, 2019
Completion date
January 2, 2022
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

angelman syndrome, chromosome 15q duplication (dup15q) syndrome